Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Valery L. Feigin, Lalit Dandona, Amanuel Alemu Abajobir et al.|The Lancet Neurology|2017Cited by 2.3k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015Marissa B Reitsma, Solomon Abrha Damtew, Peter Allebeck et al.|The Lancet|2017Cited by 2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's diseaseJavier Simón‐Sánchez, Thomas Gasser, Claudia Schulte et al.|Nature Genetics|2009Cited by 2k
Update of the MDS research criteria for prodromal Parkinson's diseaseSebastian Heinzel, Daniela Berg, Thomas Gasser et al.|Movement Disorders|2019Cited by 760
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson DiseaseHonglei Chen, Alberto Ascherio, Shumin M. Zhang et al.|Archives of Neurology|2003Cited by 635